Loading…
SIGA
SIGA Technologies Inc
NASDAQ· Healthcare· Drug Manufacturers - Specialty & Generic· CUSIP 826917106
$3.26+3.16%Price as of Sep 22, 22:37 UTC · updated once a day, after the close
Key metrics
- Market cap
- $234.23M
- P/E
- —
- Forward P/E
- 3.0x
- P/B
- 1.4x
- Dividend yield
- —
- Payout
- —
- EPS
- -$0.04
- ROE
- -1.49%
- Profit margin
- -5.19%
- Revenue growth
- -49.50%
- Beta
- 0.89
- 52-week high
- $9.45
- 52-week low
- $2.83
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -52.1% over 5Y.
today you would have $720.70▼ -27.9%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 17 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $6.11 | $6.01 | $5.60 | $7.36 | $7.52 | $7.27 | $4.77 | $7.90 | $4.85 | $2.88 | $0.42 | $1.44 | $3.27 | $2.62 | $2.52 | $14.00 | $5.80 | |
Fair price, seven ways
Seven formulas applied to what the company reported. None of them predicts a price — each answers what the stock would be worth if its assumption held. The assumption is printed next to every number, because it is the assumption that produces the result.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Cash flow
$12.03
Cash flow growing 5.0% a year for 10 years, discounted at 10%, then 2.5% forever.
Operating
$6.67
Sector median of 13.3x operating profit, less net debt. Sees the business before its financing, so debt does not distort the comparison. Banks have no EBITDA — interest is their revenue, not a cost.
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| RNAAtrium Therapeutics, Inc. | $13.64 | — | 1.0x | — | — | $233.32M |
| TNXPTonix Pharmaceuticals Holding Corp. | $13.59 | — | 1.0x | — | -81.82% | $233.08M |
| CGENCompugen Ltd | $2.49 | 6.6x | 2.7x | — | 50.64% | $235.86M |
| UTMDUtah Medical Products Inc | $72.77 |
About the company
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
- 49
- New York, United States
Company description provided by Yahoo Finance.